Analabs

ANALABS					Period (Yrs)	4
	Apr-07		Apr-11		Change	CAGR
	millions		millions
Equity	95.61		148.86		55.70%	11.70%
LT Assets	63.4		115.2		81.70%	16.10%
Current Assets	44.29		64.95		46.65%	10.04%
LT Liabilities	6.81		10.57		55.21%	11.62%
Current Liabilities	5.22		20.72		296.93%	41.15%
Sales	35.4		138.32		290.73%	40.60%
Earnings	8.36		17.67		111.36%	20.58%
Interest expense	0.04		0.27		575.00%	61.19%
D/E	0.00		0.00
ROA	7.76%		9.81%
ROE	8.74%		11.87%
Market cap	54.62		93.04		70.34%	14.24%
P/E	6.53		5.27
Earnings Yield	15.31%		18.99%
P/BV	0.57		0.63
DPO ratio (historical)	16.63%
Dividend Yield range	High		Low
	3.90%		2.50%
Capital changes	-

Year	Sales		Earnings		Net Pr Marg		Interest Exp
2006	34.14		2.7		7.9%		0.05
2007	35.4		8.36		23.6%		0.04
2008	42.63		9.33		21.9%		0.14
2009	54.65		9.19		16.8%		0.23
2010	112.96		15.39		13.6%		0.21
2011	138.32		17.67		12.8%		0.27